Mergers & Acquisitions Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 55 articles
AbbVie Cerevel acquisition closes in $8.7B neuroscience deal
immunology · 6 min
Dr. Sarah MitchellEli Lilly pipeline and deals: GLP-1, vaccines, and 2026 outlook
diabetes · 7 min
Dr. Sarah MitchellAbbVie closes $8.7B Cerevel deal as neuroscience pipeline expands
U.S. Federal Trade Commission · immunology · 5 min
Dr. Sarah MitchellMcGuireWoods' Alyssa Campbell Honored in M&A Advisor Emerging Leaders Awards
5 min
Dr. Sarah MitchellEU Draft Merger Guidelines: Capabilities Treatment Needs Revisiting
European Commission · 5 min
Dr. Sarah MitchellWeekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN
FDA · IgAN · 6 min
Dr. Sarah MitchellOtsuka kidney drug data and Pfizer AI deal: Biopharma deal tracker
IgA nephropathy · 8 min
Dr. Sarah MitchellKairos Pharma Highlights CL-741 Acquisition and 2026 Clinical Milestones: A Strategic Analysis for Pharma Decision-Makers
oncology · 5 min
Dr. Sarah MitchellChina: The Innovation Factor – Implications for Pharma BD and Investors
6 min
Dr. Sarah MitchellUtah Medical Board Scolded for Going Rogue with AI Criticism: Deal Implications for Pharma
6 min
Dr. Sarah MitchellSGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.
4 min
Dr. Sarah MitchellMercury Acquires King Courier to Grow Bay Area Logistics: Deal Intelligence for Pharma Teams
5 min
Dr. Sarah Mitchell